Healthcare Value Capital’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-150,000
Closed -$2.69M 18
2017
Q1
$2.5M Hold
150,000
4.27% 10
2016
Q4
$2.87M Hold
150,000
3.08% 12
2016
Q3
$2.64M Sell
150,000
-250,000
-63% -$3.78M 4.18% 10
2016
Q2
$4.72M Hold
400,000
5.73% 6
2016
Q1
$4.3M Buy
400,000
+30,000
+8% +$305K 6.32% 7
2015
Q4
$3.99M Hold
370,000
6.6% 6
2015
Q3
$3.6M Hold
370,000
5.13% 9
2015
Q2
$4.17M Buy
370,000
+149,000
+67% +$1.58M 4.38% 9
2015
Q1
$2.29M Buy
221,000
+21,000
+11% +$231K 2.5% 15
2014
Q4
$2.27M Buy
200,000
+125,000
+167% +$1.29M 4.14% 8
2014
Q3
$740K Buy
+75,000
New +$737K 0.71% 21
2013
Q4
Sell
-118,288
Closed -$1.11M 37
2013
Q3
$828K Hold
118,288
0.72% 37
2013
Q2
$740K Buy
+118,288
New +$722K 0.54% 45

Other funds holding AORT

Healthcare Value Capital's AORT Position: Q2 2017 in Review

Healthcare Value Capital sold out of Artivion (AORT) in Q2 2017, closing a stake of 150,000 shares — an estimated $2.69M sold.

Healthcare Value Capital first reported a position in AORT in Q2 2013 and held it in 13 quarters. The position peaked at $4.72M in Q2 2016. 127 funds tracked by Wall St. Rank hold AORT as of Q2 2017.

  • Healthcare Value Capital reported no remaining Artivion position as of Q2 2017 after selling out during the quarter.
  • Healthcare Value Capital sold 150,000 Artivion shares in Q2 2017, an estimated $2.69M.
  • Healthcare Value Capital first reported a position in Artivion in Q2 2013 and held it in 13 quarters.
  • Healthcare Value Capital's Artivion position peaked at $4.72M in Q2 2016.
  • 127 funds tracked by Wall St. Rank held Artivion as of Q2 2017.

Based on Healthcare Value Capital's 13F filing for Q2 2017, filed 10 Aug 2017.